FM Péter Szijjártó
Foreign Affairs and Trade Minister Péter Szijjártó announced in Szigetszentmiklós, at the launch of Xellia Pharmaceuticals’ new investment, that the Danish company is building an automated manufacturing plant worth HUF 28 billion (EUR 71.98 million; 1 EUR = 389 HUF), for which the government is providing HUF 7 billion in support, thereby creating 91 highly skilled jobs.
He noted that the project is extremely important not only for domestic pharmaceutical production but also for the security of the European Union’s pharmaceutical supply, and that the investment has significance beyond the project itself, as the plant will produce entirely for export, with Hungarian companies accounting for 90 percent of its suppliers.
“This provides a particularly significant opportunity for growth for small and medium-sized Hungarian businesses in the region and indeed throughout the country,” he said.
He went on to describe it as an important goal of the government to ensure that Hungarian pharmaceutical manufacturing remains at the forefront of global development, pointing out that Hungary is one of the world’s twenty largest pharmaceutical exporters and that this sector also plays a significant role in the economic transformation, as it spends the most on innovation and research and development in proportion to its revenue among Hungarian industries.
“Last year, the Hungarian pharmaceutical industry generated HUF 1,300 billion in production value, and over the past ten years, 36 major international pharmaceutical investments have been made in the country, worth HUF 260 billion,” he said.
He also mentioned that over the past ten years, 28 major investments have been made in Szigetszentmiklós (Budapest metropolitan area) with HUF 142 billion in state support, creating roughly three thousand new jobs.
Via MTI; Featured photo: MTI/Bodnár Boglárka
The post Danish Pharmaceutical Company Expands in Hungary with New Automated Plant appeared first on Hungary Today.
